Recon: Appeals court ruling would limit access to abortion pill; Ipsen’s ultra-rare bone disease drug nabs FDA approval

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy